{
    "title": "115_hr4613",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Ensuring Patient Access to \nHealthcare Records Act of 2017''.\n\nSEC. 2. PROMOTION OF ACCESS TO DATA, VIA RESEARCH AND USER FRIENDLY \n              PRESENTATIONS AND APPLICATIONS.\n\n    (a) In General.--Subtitle D of the Health Information Technology \nfor Economic and Clinical Health Act (42 U.S.C. 17921 et seq.) is \namended by adding at the end the following:\n\n   ``PART 3--HEALTH CARE CLEARINGHOUSES; DATA PROCESSING TO EMPOWER \n              PATIENTS AND IMPROVE THE HEALTH CARE SYSTEM\n\n``SEC. 13451. MODERNIZING THE ROLE OF CLEARINGHOUSES IN HEALTH CARE.\n\n    ``(a) Efforts To Promote Access to and Leveraging of Health \nInformation.--\n            ``(1) In general.--The Secretary shall, through the \n        updating of existing policies and development of policies that \n        support dynamic technology solutions, promote patient access to \n        information related to their care, including real world \n        outcomes and economic data (including claims, eligibility, and \n        payment data), in a manner that would ensure that such \n        information is available in a form convenient for the patient, \n        in a reasonable manner, and without burdening the health care \n        provider involved.\n            ``(2) Requirement.--Activities carried out under paragraph \n        (1) shall include the development of policies to enable covered \n        entities with access to health information to--\n                    ``(A) provide patient access to information related \n                to their care, including real world outcomes and \n                economic data;\n                    ``(B) develop, in accordance with HIPAA-related \n                provisions (as defined in subsection (j)), patient \n                engagement tools, reports, analyses, and presentations \n                based on population health, epidemiological, and health \n                services outcomes data, that may demonstrate a fiscal \n                or treatment benefit to patients and health plan \n                enrollees; and\n                    ``(C) promote transparency regarding the use and \n                disclosure of health information by health care \n                clearinghouses in accordance with the notice provisions \n                of subsection (e).\n    ``(b) Treatment as Covered Entity for Specified Functions.--\n            ``(1) In general.--With respect to the use and disclosure \n        of protected health information, the Secretary shall--\n                    ``(A) not consider health care clearinghouses that \n                engage in the functions described in paragraph (3) to \n                be business associates, including subcontractor \n                business associates, under HIPAA-related provisions (as \n                defined in subsection (j)(3)) regardless of the role of \n                such clearinghouses in collecting or receiving the \n                information; and\n                    ``(B) consider such clearinghouses to be covered \n                entities under such provisions of law for all purposes.\n        Such clearinghouses shall not be considered business \n        associates, or subcontractor business associates, for \n        translation of data into and out of standard format, analytic, \n        cloud computing, or any other purpose.\n            ``(2) Data accuracy and security requirement.--In order to \n        use health data as authorized by this section, a clearinghouse \n        or other covered entity engaging in activities authorized under \n        this section shall be certified to have the necessary expertise \n        and technical infrastructure to ensure the accuracy and \n        security of such claims, eligibility, and payment data through \n        receipt of an accreditation by the Electronic Healthcare \n        Network Accreditation Commission, or by an equivalent \n        accreditation program determined appropriate by the Secretary.\n            ``(3) Enhancing treatment, quality improvement, research, \n        public health efforts and other functions.--\n                    ``(A) Equivalent authority to other covered \n                entities.--Subject to paragraph (2), a health care \n                clearinghouse shall--\n                            ``(i) in addition to carrying out claims \n                        processing functions, be permitted to use and \n                        disclose protected health information without \n                        obtaining individual authorization to the same \n                        extent as other covered entities, including for \n                        purposes of treatment, payment, health care \n                        operations as permitted by section 164.506 of \n                        title 45, Code of Federal Regulations, \n                        research, and public health as permitted by \n                        section 164.512 of title 45, Code of Federal \n                        Regulations, and creating de-identified \n                        information as permitted by section 164.502(d) \n                        of title 45, Code of Federal Regulations; and\n                            ``(ii) use or disclose protected health \n                        information as required by section \n                        164.502(a)(2) of title 45, Code of Federal \n                        Regulations.\n                    ``(B) Additional authority.--\n                            ``(i) A health care clearinghouse shall be \n                        permitted to provide an individual or the \n                        personal representative of such individual \n                        access to the protected health information of \n                        such individual as described in subsection (d).\n                            ``(ii) All covered entities, including a \n                        health care clearinghouse, shall, subject to \n                        subsection (c)(2), be permitted to--\n                                    ``(I) on behalf of covered \n                                entities, use and disclose protected \n                                health information for health care \n                                operations purposes (as defined by \n                                section 164.501 of title 45, Code of \n                                Federal Regulations) without respect to \n                                whether the recipient of the \n                                information has or had a relationship \n                                with the individual;\n                                    ``(II) upon the request of a \n                                covered entity, benchmark (as defined \n                                by the Secretary pursuant to \n                                rulemaking) the operations of such \n                                covered entity against the operations \n                                of one or more other covered entities \n                                that have elected to participate in \n                                such benchmarking; and\n                                    ``(III) use and disclose protected \n                                health information to facilitate \n                                clinical trial recruitment, except that \n                                in the case the covered entity provides \n                                a consumer-facing portal or website \n                                that informs individuals of clinical \n                                trials conducted by the covered entity, \n                                the covered entity shall secure opt-in \n                                consent from the individual, or the \n                                individual's personal representative, \n                                prior to contacting an individual \n                                regarding such clinical trials unless \n                                such covered entity already has a \n                                relationship with the individual.\n                    ``(C) Clarification.--Nothing in this paragraph \n                shall expand the authority of a health care \n                clearinghouse or any other covered entity to use or \n                disclose protected health information for marketing \n                purposes under sections 164.501 and 164.508(a)(3) of \n                title 45, Code of Federal Regulations.\n    ``(c) Authorities Relating to Data Processing.--\n            ``(1) In general.--In carrying out HIPAA-related \n        provisions, the Secretary shall permit a health care \n        clearinghouse to aggregate protected health information, within \n        the clearinghouse and among other clearinghouses, that the \n        clearinghouse possesses in order to carry out the functions \n        described in subsection (b)(3). Subject to section \n        164.502(a)(5)(i) of title 45, Code of Federal Regulations, a \n        health care clearinghouse may carry out the functions described \n        in subsection (b)(3) without obtaining individual authorization \n        under section 164.508 of title 45, Code of Federal Regulations.\n            ``(2) Privacy.--For purposes of clauses (ii) through (iv) \n        of subsection (b)(3)(B), with respect to any report, analysis, \n        or presentation provided by the covered entity to a third \n        party, such report, analysis, or presentation--\n                    ``(A) shall include only de-identified data; or\n                    ``(B) shall include, subject to a qualifying data \n                use agreement (as defined in subsection (j)), protected \n                health information.\n            ``(3) Clarification; fee permitted.--\n                    ``(A) In general.--Nothing in this paragraph shall \n                be construed as affecting an individual's right to \n                access claims and payment records in HIPAA standard \n                format, in accordance with section 164.524 of title 45, \n                Code of Federal Regulations.\n                    ``(B) Fee permitted.--If an individual or a \n                personal representative of the individual requests a \n                copy of records in HIPAA standard format a health care \n                clearinghouse may charge a reasonable, cost-based fee \n                so far as such fee is in accordance with section \n                164.524(c)(4) of title 45, Code of Federal Regulations.\n    ``(d) Comprehensive Records at the Request of an Individual.--\n            ``(1) In general.--When a health care clearinghouse \n        receives a written request from an individual or the personal \n        representative of the individual for the protected health \n        information of the individual, the clearinghouse shall provide \n        to the individual a comprehensive record of such information \n        (across health care providers and health plans and longitudinal \n        in scope), unless the clearinghouse determines in its sole \n        discretion that providing a comprehensive record is not \n        technologically feasible.\n            ``(2) Purchase from other clearinghouses.--In preparing a \n        comprehensive record for an individual under paragraph (1), a \n        health care clearinghouse may, with the permission of the \n        individual, purchase the protected health information of the \n        individual from one or more other health clearinghouses (and \n        the amount of such purchase may be included in a fee that is \n        fair market value, as defined in subsection (j)(2), charged to \n        the individual.\n    ``(e) Situations Not Involving Direct Interaction With \nIndividuals.--Sections 164.400 through 164.414 (relating to breach \nnotification) and sections 164.520 through 164.528 (relating to \nindividual rights) of title 45, Code of Federal Regulations, shall \napply to a health care clearinghouse that engages in the functions \ndescribed in subsection (b)(3) to the extent that such clearinghouse \nhas current contact information pursuant to direct interaction with the \nindividual involved. If the clearinghouse does not have direct \ninteraction with the individual involved, the clearinghouse shall \nprovide notice of any breach of unsecured protected health information \nto the covered entity that does have direct interaction with the \nindividual involved. The clearinghouse shall not be required to report \na breach if the protected health information is rendered unusable, \nunreadable, or indecipherable to unauthorized persons through the use \nof a technology or methodology specified by the Secretary in the \nguidance issued under section 13402(h)(2). The clearinghouse shall also \nprovide a notice of privacy practices on its website.\n    ``(f) Transition.--\n            ``(1) In general.--Except where specifically stated, \n        nothing in this section shall be construed to apply to \n        clearinghouses to the exclusion of other covered entities or to \n        provide a health care clearinghouse greater authority to use \n        and disclose protected health information than that provided to \n        another covered entity.\n            ``(2) Existing agreements.--With respect to agreements \n        entered into by a health care clearinghouse prior to the date \n        of enactment of this section, a provision of such an agreement \n        that conflicts with this section shall not have any legal force \n        or effect. The preceding sentence may not be construed as \n        affecting any provision of an agreement that does not conflict \n        with this section.\n    ``(g) Safe Harbor and Clarification of Liability.--In the case of a \nhealth care clearinghouse that engages in a function described in \nsubsection (b), only that clearinghouse may be held liable for a \nviolation of a HIPAA-related provision (and a covered entity that \nprovided data or data access to the clearinghouse shall not be liable \nfor such violations).\n    ``(h) Enforcement.--Section 13410(a)(2) shall apply to this section \nin the same manner as such section applies to parts 1 and 2.\n    ``(i) Relation to Other Laws.--\n            ``(1) Application of hitech rule.--Section 13421 shall \n        apply to this section in the same manner as such section \n        applies to parts 1 and 2, except to the extent that such \n        section 13421 concerns section 1178(a)(2)(B) of the Social \n        Security Act.\n            ``(2) State laws regarding unfair or deceptive acts or \n        practices.--This part shall not be construed to preempt the law \n        of any State that prohibits unfair or deceptive acts or \n        practices or limit the authority of State attorneys general to \n        enforce such laws.\n    ``(j) Definitions.--In this part:\n            ``(1) De-identified.--The term `de-identified', with \n        respect to health information, means such information that is \n        not individually identifiable as determined in accordance with \n        the standards under section 164.514(b) of title 45, Code of \n        Federal Regulations.\n            ``(2) Fair market value.--The term `fair market value' \n        means the price that a person reasonably knowledgeable and \n        interested in buying a given product or service would pay to a \n        person reasonably knowledgeable and interested in selling the \n        product or service.\n            ``(3) Health care clearinghouse.--The term `health care \n        clearinghouse' has the meaning given such term in section 1171 \n        of the Social Security Act.\n            ``(4) HIPAA-related provision.--The term `HIPAA-related \n        provision' means the provisions of each of the following:\n                    ``(A) This subtitle.\n                    ``(B) Part C of title XI of the Social Security \n                Act.\n                    ``(C) Regulations promulgated pursuant to sections \n                262(a) and 264(c) of the Health Insurance Portability \n                and Accountability Act of 1996 or this subtitle.\n            ``(5) Individual.--The term `individual', with respect to \n        protected health information, has the meaning applicable under \n        section 160.103 of title 45, Code of Federal Regulations.\n            ``(6) Qualifying data use agreement.--The term `qualifying \n        data use agreement' means an agreement, which may be \n        electronic, that--\n                    ``(A) establishes the permitted uses and \n                disclosures of protected health information by the \n                recipient;\n                    ``(B) limits such uses and disclosures to the \n                original purpose of disclosure under subsection \n                (b)(3)(B); and\n                    ``(C) provides that the data recipient will--\n                            ``(i) not use or further disclose the \n                        information other than as permitted by the \n                        qualifying data use agreement or as otherwise \n                        required by law;\n                            ``(ii) use appropriate safeguards to \n                        prevent use or disclosure of the information \n                        other than as provided for by the qualifying \n                        data use agreement; and\n                            ``(iii) ensure that any agents to whom it \n                        provides the data agree to the same \n                        restrictions and conditions that apply to the \n                        data recipient with respect to such \n                        information.''.\n    (b) Regulations.--Not later than 180 days after the date of the \nenactment of this Act, the Secretary of Health and Human Services shall \npromulgate regulations to carry out the amendment made by subsection \n(a).\n    (c) Conforming Amendment.--Section 1171(2) of the Social Security \nAct (42 U.S.C. 1320d(2)) is amended by inserting before the period the \nfollowing: ``or receives a standard transaction from another entity and \nprocesses or facilitates the processing of health information into \nnonstandard format or nonstandard data content for the receiving \nentity. Such term also includes an entity that carries out such \nprocessing functions, transmits standard health care claims, transmits \nhealth care claim payments or provides advice on such, and transmits \nany standard transactions on behalf of a HIPAA-covered entity and in \naddition, engages in any authority of such entity described in \nsubsection (b)(3) of section 13451 of the Health Information Technology \nfor Economic and Clinical Health Act''."
}